In summary, MEN1 is characterized by a more severe bone disease because of the coexistence of PHPT with other endocrinopathies that negatively affect bone mass, whereas PHPT in the context of MEN2 syndrome is either milder (MEN2A) or scarcely occurs (MEN2B). The gene discussed is RET; the disease is endocrine system disorder.